Tandem Diabetes Care has secured a new FDA clearance for its insulin dose-calculating algorithm, opening up its use to adults with Type 2 diabetes. The Control-IQ+ program—now with the added ...

The new type 2 diabetes treatment algorithm consensus statement from the American Association of Clinical Endocrinologists (AACE), running to 48 pages, has been published online and is available for ...

SEATTLE — The latest American Association of Clinical Endocrinology (AACE) type 2 diabetes management algorithm uses graphics to focus on individualized care while adding newly compiled information ...

A University of Virginia Center for Diabetes Technology-developed algorithm – paired with a continuous glucose monitor – can help users better manage their type 2 diabetes by recommending insulin-dose ...

In addition to BP control, early and intensive management of dyslipidemia is key to preventing macrovascular complications in T2D. The AACE recommends the following lipid targets for patients with T2D ...

CHARLOTTESVILLE, Va. — A University of Virginia Center for Diabetes Technology-developed algorithm, paired with a continuous glucose monitor, can help users better manage their Type 2 diabetes by ...

A new study led by Marc D. Breton, PhD, found that a University of Virginia Center for Diabetes Technology-developed algorithm – paired with a continuous glucose monitor – can help users better manage ...

This is a syndicated post stub. Clinical Advisor, a trusted source of medical news and feature content for healthcare providers, offers clinicians insight into the latest research to inform clinical ...

During a session at AdvaMed’s annual MedTech Conference in Boston this fall, when asked which areas of medtech are currently looking most exciting from an R&D perspective, Medtronic CEO Geoff Martha ...